{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:11:58Z","timestamp":1760202718142},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ijcard.2016.10.083","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T05:01:23Z","timestamp":1478149283000},"page":"1-3","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients"],"prefix":"10.1016","volume":"242","author":[{"given":"Hong","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijcard.2016.10.083_bb0005","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.083_bb0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4065\/79.5.620","article-title":"Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial","volume":"2004","author":"Goldberg","year":"2004","journal-title":"Mayo Clin. Proc."},{"issue":"10","key":"10.1016\/j.ijcard.2016.10.083_bb0015","first-page":"2081","article-title":"Ezetimibe\/Simvastatin (vytorin) for hypercholesterolemia","volume":"72","author":"Goldman-Levine","year":"2005","journal-title":"Am. Fam. Physician"},{"issue":"10","key":"10.1016\/j.ijcard.2016.10.083_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9149(98)00726-7","article-title":"Importance of endothelial function in mediating the benefits of lipid-lowering therapy","volume":"82","author":"Brown","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.083_bb0025","first-page":"123","article-title":"Safty of clinical application of stains","volume":"26","author":"Yang","year":"2006","journal-title":"Basic Clin. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.083_bb0030","first-page":"129","article-title":"New progress of ezetimibe and stains combination therapy in lipid-lowering","volume":"11","author":"Xie","year":"2013","journal-title":"Cent. South Pharm."},{"issue":"23","key":"10.1016\/j.ijcard.2016.10.083_bb0035","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2016.10.083_bb0040","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction the Framingham Heart Study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2016.10.083_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacl.2008.01.001","article-title":"Effect of ezetimibe\/simvastatin vs atorvastatin on lowering levels of LDL-C and non\u2013HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes","volume":"2","author":"Weinstock","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ijcard.2016.10.083_bb0050","first-page":"63","article-title":"The application of high-sensitivity C-reactive protein detection in diagnosis and treatment of atherosclerotic disease","volume":"04","author":"Yan","year":"2002","journal-title":"J. Diagn. Concepts Pract."},{"issue":"27","key":"10.1016\/j.ijcard.2016.10.083_bb0055","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2016.10.083_bb0060","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2016.10.083_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcard.2016.10.083_bb0070","volume":"106","author":"Program NCE","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2016.10.083_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0735-1097(96)82380-1","article-title":"Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels","volume":"28","author":"Clarkson","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.10.083_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI116983","article-title":"Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level","volume":"93","author":"Sorensen","year":"1994","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2016.10.083_bb0085","article-title":"Indexes of Ldl Particle-Size Closely Relate to Endothelial Dysfunction","volume":"1993","author":"Dyce","year":"1993"},{"issue":"8","key":"10.1016\/j.ijcard.2016.10.083_bb0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199502233320802","article-title":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion","volume":"332","author":"Anderson","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2016.10.083_bb0095","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.89.6.2519","article-title":"Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia","volume":"89","author":"Egashira","year":"1994","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2016.10.083_bb0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2016.10.083_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ijcard.2016.10.083_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering\u2014are they clinically relevant?","volume":"24","author":"Bonetti","year":"2003","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2016.10.083_bb0115","doi-asserted-by":"crossref","first-page":"1K","DOI":"10.1016\/j.amjcard.2008.10.002","article-title":"The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia","volume":"102","author":"Fruchart","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2016.10.083_bb0120","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1368-5031.2004.00289.x","article-title":"Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia","volume":"58","author":"Davidson","year":"2004","journal-title":"Int. J. Clin. Pract."},{"issue":"8","key":"10.1016\/j.ijcard.2016.10.083_bb0125","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/14656566.2015.1041504","article-title":"Ezetimibe plus simvastatin for the treatment of hypercholesterolemia","volume":"16","author":"Gryn","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.ijcard.2016.10.083_bb0130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacc.2006.10.064","article-title":"Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?","volume":"49","author":"Piorkowski","year":"2007","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316332715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316332715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T21:21:04Z","timestamp":1536268864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316332715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":26,"alternative-id":["S0167527316332715"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.083","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}